106 related articles for article (PubMed ID: 17440116)
1. Regulation of cytochrome P450 2E1 under hypertonic environment through TonEBP in human hepatocytes.
Ito T; Asakura K; Tougou K; Fukuda T; Kubota R; Nonen S; Fujio Y; Azuma J
Mol Pharmacol; 2007 Jul; 72(1):173-81. PubMed ID: 17440116
[TBL] [Abstract][Full Text] [Related]
2. Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cells.
Ito T; Fujio Y; Hirata M; Takatani T; Matsuda T; Muraoka S; Takahashi K; Azuma J
Biochem J; 2004 Aug; 382(Pt 1):177-82. PubMed ID: 15142033
[TBL] [Abstract][Full Text] [Related]
3. Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells.
Hasler U; Jeon US; Kim JA; Mordasini D; Kwon HM; Féraille E; Martin PY
J Am Soc Nephrol; 2006 Jun; 17(6):1521-31. PubMed ID: 16641150
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional analysis of a novel human CYP2E1 far upstream enhancer.
Shadley JD; Divakaran K; Munson K; Hines RN; Douglas K; McCarver DG
Mol Pharmacol; 2007 Jun; 71(6):1630-9. PubMed ID: 17353354
[TBL] [Abstract][Full Text] [Related]
5. Determination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter.
Abdel-Razzak Z; Garlatti M; Aggerbeck M; Barouki R
Biochem Pharmacol; 2004 Oct; 68(7):1371-81. PubMed ID: 15345327
[TBL] [Abstract][Full Text] [Related]
6. Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone.
Peng HM; Coon MJ
Mol Pharmacol; 1998 Oct; 54(4):740-7. PubMed ID: 9765518
[TBL] [Abstract][Full Text] [Related]
7. Post-translational inhibition of cytochrome P-450 2E1 expression by chlomethiazole in Fao hepatoma cells.
Simi A; Ingelman-Sundberg M
J Pharmacol Exp Ther; 1999 May; 289(2):847-52. PubMed ID: 10215662
[TBL] [Abstract][Full Text] [Related]
8. The pig CYP2E1 promoter is activated by COUP-TF1 and HNF-1 and is inhibited by androstenone.
Tambyrajah WS; Doran E; Wood JD; McGivan JD
Arch Biochem Biophys; 2004 Nov; 431(2):252-60. PubMed ID: 15488474
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activity of the tandem repeat polymorphism in the 5'-flanking region of the human CYP2E1 gene.
Nomura F; Itoga S; Uchimoto T; Tomonaga T; Nezu M; Shimada H; Ochiai T
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):42S-46S. PubMed ID: 12960506
[TBL] [Abstract][Full Text] [Related]
10. A repressive cross-regulation between catalytic and promoter activities of the CYP1A1 and CYP2E1 genes: role of H(2)O(2).
Morel Y; de Waziers I; Barouki R
Mol Pharmacol; 2000 Jun; 57(6):1158-64. PubMed ID: 10825386
[TBL] [Abstract][Full Text] [Related]
11. Suppression of cytochrome P450 2E1 promoter activity by interferon-gamma and loss of response due to the -71G>T nucleotide polymorphism of the CYP2E1*7B allele.
Qiu LO; Linder MW; Antonino-Green DM; Valdes R
J Pharmacol Exp Ther; 2004 Jan; 308(1):284-8. PubMed ID: 14566010
[TBL] [Abstract][Full Text] [Related]
12. Discovery of osmosensitive transcriptional regulation of human cytochrome P450 3As by the tonicity-responsive enhancer binding protein (nuclear factor of activated T cells 5).
Kosuge K; Chuang AI; Uematsu S; Tan KP; Ohashi K; Ko BC; Ito S
Mol Pharmacol; 2007 Oct; 72(4):826-37. PubMed ID: 17600221
[TBL] [Abstract][Full Text] [Related]
13. Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element.
Nishinaka T; Ichijo Y; Ito M; Kimura M; Katsuyama M; Iwata K; Miura T; Terada T; Yabe-Nishimura C
Toxicol Lett; 2007 May; 170(3):238-47. PubMed ID: 17449203
[TBL] [Abstract][Full Text] [Related]
14. A novel lipopolysaccharide-modulated Jun binding repressor in intron 2 of CYP2E1.
Tindberg N; Bengtsson I; Hu Y
J Neurochem; 2004 Jun; 89(6):1336-46. PubMed ID: 15189336
[TBL] [Abstract][Full Text] [Related]
15. Hypertonicity regulates the aquaporin-2 promoter independently of arginine vasopressin.
Kasono K; Saito T; Saito T; Tamemoto H; Yanagidate C; Uchida S; Kawakami M; Sasaki S; Ishikawa SE
Nephrol Dial Transplant; 2005 Mar; 20(3):509-15. PubMed ID: 15671070
[TBL] [Abstract][Full Text] [Related]
16. Cloning of canine cytochrome P450 2E1 cDNA: identification and characterization of two variant alleles.
Lankford SM; Bai SA; Goldstein JA
Drug Metab Dispos; 2000 Aug; 28(8):981-6. PubMed ID: 10901710
[TBL] [Abstract][Full Text] [Related]
17. Role of the genetic polymorphisms in the 5'-flanking region for transcriptional regulation of the human CYP2E1 gene.
Uchimoto T; Itoga S; Nezu M; Sunaga M; Tomonaga T; Nomura F
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S36-42. PubMed ID: 17331164
[TBL] [Abstract][Full Text] [Related]
18. Role and importance of polymorphisms with respect to DNA methylation for the expression of CYP2E1 enzyme.
Naselli F; Catanzaro I; Bellavia D; Perez A; Sposito L; Caradonna F
Gene; 2014 Feb; 536(1):29-39. PubMed ID: 24333271
[TBL] [Abstract][Full Text] [Related]
19. Examination of a CYP2E1 repeat polymorphism in a monkey model of alcohol abuse.
Walker SJ; Grant KA; Vrana KE
Alcohol Clin Exp Res; 2001 Aug; 25(8):1114-8. PubMed ID: 11505041
[TBL] [Abstract][Full Text] [Related]
20. Human hepatocytes are protected from ethanol-induced cytotoxicity by DADS via CYP2E1 inhibition.
Shimada M; Liu L; Nussler N; Jonas S; Langrehr JM; Ogawa T; Kaminishi M; Neuhaus P; Nussler AK
Toxicol Lett; 2006 Jun; 163(3):242-9. PubMed ID: 16356668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
